Canada Active Implantable Medical Devices Market Insight
Published: 01 June 2026 | Report Format: Electronic (PDF)
Canada active implantable medical devices market is showing growth owing to increased cases of cardiovascular and neurological diseases, increased demand for minimally invasive surgeries, and advances in healthcare technology.
Canada Active Implantable Medical Devices Insights Forecasts to 2035
- The Canada Active Implantable Medical Devices System Market Size was Valued at USD 3.4 Billion in 2025.
- The Market Size is expected to grow at a CAGR of around 7.31% from 2025 to 2035.
- The Canada Active Implantable Medical Devices System Market Size is Projected to Reach USD 6.36 Billion by 2035.
Notable Insights for the Canada Active Implantable Medical Devices Market
- By product Type, cardiovascular implantable devices held the largest market share with about 44% share in 2025 in Canada’s active implantable medical devices market due to the prevalence of cardiovascular disorders, high use of pacemakers and ICDs (implantable cardioverter defibrillators), and increasing remote cardiac monitoring.
- In terms of material, metallic implants held the highest market share of approximately 68% in 2025 due to their high tensile strength, excellent durability, anti-corrosion properties, and wide usage in cardiovascular, orthopedic, dental, and neurological implants in Canada’s healthcare facilities.
- The country's expenditure on healthcare has surpassed CAD 370 billion in 2024, with per capita expenditure on healthcare estimated at around CAD 9,054, allowing access to innovative implantable products. Besides, close to 80% of medical devices employed in Canada are imports, implying substantial interest in innovative active implantable medical devices and treatments.
- Current technology adoption trends, such as those involving MRI-compliant devices, wireless monitoring, and digital health systems, are growing fast in the country. Health Canada is rolling out a national UDID scheme for high-risk implantable devices, with Class III and Class IV AIMDs required to conform to strict MDSAP and ISO 13485 requirements.
Download the eBook (ToC)
Why Buy This Report
- Comprehensive analysis of the Canadian market for active implantable medical devices, such as market sizing, driving forces, technology advances, competitive scenario, and future opportunities available in the industry.
- Perform an analysis of the demand for different types of devices like cardiac rhythm management devices, neurostimulators, cochlear implants, drug delivery implants, and more innovative implantable devices.
- Explore potential investment areas due to increasing prevalence of diseases, growing aging population, digital health technology integration, remote patient monitoring, and the advent of next-gen implantable medical devices.
Competitive Analysis:
The report offers the appropriate analysis of the key organisations/companies involved within the Canada active implantable medical devices market, along with a comparative evaluation primarily based on their product offerings, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in the Canada Active Implantable Medical Devices Market
- Kardium
- Conavi Medical
- Profound Medical
- Canary Medical
- Baylis Medical Technologies
- Titan Medical
- CardioComm Solutions
- Agile MV
- Bionic Power
- BioIntegral Surgical
Recent Developments:
- In January 2026, a team of researchers at the University of Waterloo created magnetically controlled micro-robots that could be used for minimally invasive operations by creating active implantable medical micro-devices to facilitate advancements within implantable medical technology in the future.
- In June 2025, Medtronic and IRCAD North America collaborated on setting up a training facility for physicians regarding robotic surgery and implantable medical devices to pave the way for future active implantable devices in North America, including Canada.
Market Segmentation:
Canada Active Implantable Medical Devices Market, By Product Type
- Cardiovascular
- Orthopedic
- Dental
- Ophthalmic
- Neurological
Canada Active Implantable Medical Devices Market, By Material
- Metallic
- Ceramic
- Polymeric
- Bioactive and Biocompatible
Canada Active Implantable Medical Devices Market, By End-User
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Research Institutions
- Specialty Care Centers
Expert Views:
The Canadian active implantable medical devices industry is poised for robust growth throughout the forecast period due to increasing incidences of cardiovascular disease, neurological diseases, hearing problems, and chronic pain disorders. The development in technologies, including miniaturization, wireless technology, artificial intelligence, and other healthcare technologies, has led to enhanced treatment efficacy and favourable patient outcomes. In addition, the increasing investment in the healthcare sector, along with the adoption of digital health technologies, provides ample opportunity for players operating in the implantable devices industry in Canada.
Author: Sanket and Pranali By Spherical Insights and Consulting